查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198697

导尿管市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Urinary Catheters Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在 2022-2027 年的预测期内，导尿管市场预计将以近 5.5% 的复合年增长率增长。

导尿管市场预计将受到 COVID-19 情景的深刻影响。 随着病例数量仍在上升，以及一些患有 COVID-19 的危重患者使用导尿管，预计对导尿管的需求也会增加。 预计这将对导尿管的需求产生积极影响。

推动导尿管市场增长的主要因素包括尿失禁患病率上升、老年人口增加以及导尿管材料技术进步。

增加的资金将支持在市场上推出更多创新产品。 例如，2020 年 12 月，Ingenion Medical Ltd 从 Innovative UK 获得了约 10 万英镑的资金，用于开发产品 CymActive 导尿管。 这是一种新型医疗器械，旨在治疗男性尿潴留患者。 尿失禁是一种诊断不足和报告不足的疾病，可能会随着年龄的增长而增加，主要影响老年人。 此外，根据世界老龄化人口报告，2019年，约有7.029亿人超过65岁，预计到2050年这一数字将达到15.489亿。 因此，这有望推动市场增长。

导尿管市场趋势

良性前列腺增生症 (BPH) 预计在预测期内显示导尿管市场显着增长

预计在预测期内，良性前列腺增生 (BPH) 将在导尿管市场出现显着增长。 然而，随着 COVID-19 的爆发，BPH 的诊断和治疗出现延误。 这对该细分市场所研究的市场产生了总体负面影响。 根据 2020 年 6 月发表的“Gravas S, Fournier G, Oya M, et al. Prioritizing urological surgery in the COVID-19 era: a global reflection on guidelines”的研究，对 76 个国家的约 2,494 名泌尿科医生进行了调查，BPH 是在非肿瘤治疗中被列为最低的治疗优先级。

BPH 在老年男性中很常见。 2020 年 5 月发表的一项题为“提示老年男性良性前列腺增生的下尿路症状患病率及相关因素”的研究发现，随着人口老龄化，BPH 患病率在中国人群中也会增加。正在上升。 BPH常伴有尿失禁、尿频、排尿困难等症状。 因此，良性前列腺增生的增加预计将影响尿失禁的总体负担并推动该领域的市场增长。

北美市场份额最大

北美在导尿管市场中占有很大份额，预计在预测期内也将呈现类似趋势。 预计 COVID-19 的爆发将对市场产生重大影响。 2021 年 2 月，加拿大卫生部批准了 Bactguard 设计的 TempSensor 导管。 由于一些重症 COVID-19 患者使用了导尿管，因此此类产品的推出可能会对所研究的市场产生积极影响。

不断增加的尿失禁负担和不断增长的老年人口正在推动该地区的市场。 根据泌尿外科护理基金会 2019 年修订版，美国三分之一的男性和女性患有尿失禁。 大约有 3300 万人患有膀胱过度活动症，表现为伴有或不伴有尿急、尿频和急迫性尿失禁。

此外，技术先进产品的推出有望在预测期内推动该地区的市场发展。 例如，2019 年 2 月，Safe Medical Design Inc. 的产品 Signal Catheter 获得了美国食品和药物管理局 (US FDA) 的批准。 因此，上述因素有望对市场增长产生积极影响。

导尿管市场竞争者分析

导尿管市场相当分散，有一些大大小小的参与者。 市场进入者专注于研发，为市场开发技术先进的产品。 新进入者的壁垒很高，少数大公司占据最大份额。 主要参与者包括 B Braun Melsungen AG、Boston Scientific Corporation、Teleflex Inc. 和 Medtronic PLC。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 尿失禁患病率上升
    • 老年人口增加
    • 导管所用材料的技术进步
  • 市场製约因素
    • 导尿管相关尿路感染 (CAUTI) 的风险
    • 尿失禁的替代疗法
  • 行业吸引力 - 波特五力分析
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品类型
    • 留置（Foley）导管
    • 间歇性导尿管
    • 体外导管
  • 通过申请
    • 良性前列腺增生症 (BPH)
    • 尿失禁
    • 脊髓损伤
    • 其他用途
  • 区域信息
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Amsino International Inc.
    • B Braun Melsungen AG
    • Boston Scientific Corporation
    • Coloplast AS
    • ConvaTec Group PLC
    • Cook Medical
    • Cure Medical LLC
    • Hollister Incorporated
    • Medtronic PLC
    • Teleflex Incorporated
    • C R Bard
    • Beckton Dickinson and Company
    • ASID BONZ GmbH
    • CompactCath
    • Go Medical Industries Pty Ltd

第7章 市场机会今后动向

简介目录
Product Code: 60487

The urinary catheters market is expected to register a CAGR of nearly 5.5% during the forecast period of 2022-2027.

A profound impact on the urinary catheter market is expected due to the COVID-19 scenario. As the number of cases is still on the rise, the demand for urinary catheters is also expected to increase since urinary catheters are used in some critically ill patients suffering from COVID-19. Thus, this is expected to impact the demand for urinary catheters positively.

The primary factors driving the growth of the urinary catheter market include the rising prevalence of urinary incontinence, the growing geriatric population, and technological advancement in the material used for catheters.

Increasing funding provides support for more innovative product launches in the market. For instance, in December 2020, Ingenion Medical Ltd received about GBP 100,000 funding from the Innovative UK to develop its product CymActive urinary catheter. It is a novel medical device that is designed for treating male patients suffering from urinary retention. Urinary incontinence is an underdiagnosed and underreported condition that is likely to increase with age and majorly affects the elderly population. Furthermore, as per the World Ageing Population report, in 2019, about 702.9 million people living were aged 65 years and above, and this number is expected to reach 1,548.9 million by 2050. Thus, this is expected to fuel the market growth.

Urinary Catheters Market Trends

Benign Prostate Hyperplasia (BPH) is Expected to Show a Significant Growth in the Urinary Catheter Market During the Forecast Period

Benign prostate hyperplasia (BPH) is expected to show significant growth in the urinary catheter market during the forecast period. However, with the COVID-19 outbreak, a delay in diagnosis and treatment was observed in the case of BPH. This overall impacted negatively on the market studied in this segment. As per the study 'Gravas S, Fournier G, Oya M, et al. Prioritising urological surgery in the COVID-19 era: a global reflection on guidelines', published in June 2020, about 2,494 urologists were surveyed from 76 countries wherein BPH was preferred as one of the lowest priorities in terms of treatment in non-oncological procedures.

BPH is a very common condition among older men. A study titled, 'The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males', published in May 2020, revealed that with increasing aging, the prevalence of BPH also increased among the Chinese population. BPH is often associated with the conditions such as urinary incontinence, frequent urination, and urine initiation difficulties. Thus, the growing burden of BPH is further expected to impact the overall burden of urinary incontinence, thereby flourishing the market growth in this segment.

North America Accounted for the Largest Share in the Market

North America occupied a major share in the urinary catheter market, and the region is expected to show a similar trend over the forecast period. A profound impact is expected on the market due to the COVID-19 outbreak. In February 2021, Health Canada approved the TempSensor catheter designed by Bactguard. As urinary catheters are being used in some cases of critically ill COVID-19 patients, the introduction of such products can positively impact the market studied.

The growing burden of urinary incontinence and the rising geriatric population are some of the driving factors in this region for the market studied. According to the Urology Care Foundation, 2019 revision, one-third of men and women in the United States suffer from urinary incontinence. About 33 million have overactive bladders, representing symptoms of urgency, frequency, and with or without urge incontinence.

Furthermore, with the introduction of technologically advanced products, the market in this region is expected to fuel over the forecast period. For instance, in February 2019, Safe Medical Design Inc. received approval from the United States Food & Drug Administration (US FDA) for its product Signal Catheter. Thus, the factors mentioned above are expected to impact the market growth positively.

Urinary Catheters Market Competitor Analysis

The urinary catheter market is moderately fragmented, with the presence of a few major players and small players. The market players are focusing on R&D to develop technologically advanced products in the market. The barriers for the new entrants are high in this industry, and hence, few major market players hold the maximum market share. Some of the major players in the market are B Braun Melsungen AG, Boston Scientific Corporation, Teleflex Inc., and Medtronic PLC, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Urinary Incontinence
    • 4.2.2 Growing Geriatric Population
    • 4.2.3 Technological Advancement in the Material Used for Catheters
  • 4.3 Market Restraints
    • 4.3.1 Risk of Catheter-associated Urinary Tract Infection (CAUTI)
    • 4.3.2 Alternative Treatment Options for Urinary Incontinence
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Indwelling (Foley) Catheters
    • 5.1.2 Intermittent Catheters
    • 5.1.3 External Catheters
  • 5.2 By Application
    • 5.2.1 Benign Prostate Hyperplasia (BPH)
    • 5.2.2 Urinary Incontinence
    • 5.2.3 Spinal Cord Injury
    • 5.2.4 Other Applications
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amsino International Inc.
    • 6.1.2 B Braun Melsungen AG
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Coloplast AS
    • 6.1.5 ConvaTec Group PLC
    • 6.1.6 Cook Medical
    • 6.1.7 Cure Medical LLC
    • 6.1.8 Hollister Incorporated
    • 6.1.9 Medtronic PLC
    • 6.1.10 Teleflex Incorporated
    • 6.1.11 C R Bard
    • 6.1.12 Beckton Dickinson and Company
    • 6.1.13 ASID BONZ GmbH
    • 6.1.14 CompactCath
    • 6.1.15 Go Medical Industries Pty Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS